NEWPORT BEACH, Calif.--(BUSINESS WIRE)--ROTH Capital Partners (ROTH), www.roth.com, a full-service investment bank recognized for providing financing and advisory services to emerging growth companies in the US and China, today announced that its Director of Research, Mark Tobin, will speak at the CCG hosted China Rising Investment Conference scheduled for May 17, 2010 at the Grand Hyatt Hotel in New York City.

Mr. Tobin will appear on a noon panel entitled: "Five leading equity analysts provide their top China Stocks for 2010 (and a few shorts for dessert)," and will discuss ROTH’s view on the most promising sectors within China and present his top pick for 2010.

At last year’s China Rising Investment Conference, Mr. Tobin’s Top Pick was Hainan-based Jinpan International (Nasdaq: JST), a manufacturer of industrial electrical equipment for power distribution and wind energy applications. The stock subsequently gained 101.1% from May 17, 2009, to December 31, 2009.*

“ROTH’s research team seeks to identify high quality companies with strong growth prospects, but trading at discounted valuations,” said Tobin. “We view China as home to many such companies. Since we established our China research team in 2005, ROTH analysts have analyzed nearly 150 U.S.-listed Chinese companies, conducting hundreds of facility visits, management meetings, and industry due diligence. This in-depth research effort provides us with valuable perspective across the sector and differentiates our research. We are most excited about those companies that possess best-in-class attributes, including high-caliber management, efficient operations, and defensible technology, that are also aligned with favorable macro and sector trends. Within the U.S.-listed Chinese sector, many of these equities trade at deeply discounted valuations compared to global peers and Chinese peers listed on Asian exchanges, creating what we view as a compelling investment opportunity.

“We continue to view China’s economic outlook as one of the most favorable in the world,” continued Tobin. “China deftly navigated the global downturn and has recovered rapidly. Based on extensive conversations with Chinese business leaders, we believe confidence in continued growth remains high. We view certain sectors as particularly attractive, including energy, agriculture, consumer, education, infrastructure, and healthcare. We look forward to discussing these themes at the China Rising Investment Conference.”

ROTH strives to be the trusted source for institutional investors for research, due diligence, and industry knowledge within the U.S.-listed China sector. ROTH’s 12-member China research team, including 8 professionals in our Shanghai Representative Office, currently maintains research coverage an industry-leading 66 U.S.-listed Chinese companies. Since 2006, ROTH has accompanied U.S. investors on visits to more than 75 company facilities in mainland China and hosted approximately 500 China company presentations at its U.S. and China conferences. We serve as a market maker for over 75 Chinese equities. Finally, since 2003, ROTH has raised more than $2.8 billion through 67 transactions for U.S.-listed Chinese companies.

The China Rising Investment Conference will allow attendees to meet with CEOs and CFOs from approximately 30 Chinese companies spanning diverse sectors including infrastructure, consumer, healthcare, technology, agriculture, industrials, energy and clean technology. The conference will feature keynote speaker David Munoz, managing director at Blackrock Global Investment Management, and respected market commentator Robert Hsu of China Strategy.

For more information on the conference - agenda, updated list and schedule of presenting companies, Webcast information and a list of sponsors - please visit: www.chinarisingconference.com

About Roth Capital Partners, LLC:

Roth Capital Partners, LLC (ROTH), is a relationship-driven full service investment bank focused on identifying opportunities for institutional investors in U.S.-listed equity securities of companies based in the U.S. and China. Headquartered in Newport Beach, CA, with offices throughout the U.S. and a Shanghai Representative Office, the employee-owned firm provides analytical research, trading, capital raising, and business combination advisory services. ROTH seeks to implement innovative financing strategies to efficiently meet the liquidity and valuation requirements of both its corporate and institutional investor clients.

*Past performance is not a guaranteed of future results. Roth Capital Partners, LLC ("ROTH") expects to receive or intends to seek compensation for investment banking or other business relationships with the covered companies mentioned in this press release in the next three months. For important disclosure information regarding the covered companies in this press release, please contact: The Director of Research at 800-678-9147 or write to: Roth Capital Partners, LLC, Attention: Director of Research, 24 Corporate Plaza, Newport Beach, CA 92660.

Key Words:

Small-Cap Stocks

Micro-Cap Stocks

PIPEs

Media

Energy

Software

Industrials

Retail

Technology

Healthcare

Financial Services

Consumer Goods

China

Institutional Investor

Medical Devices

Spec Pharma

Pharmaceuticals

Generics

Drug Delivery

Biotechnology

Registered Direct

Jinpan International

China IPO